Literature DB >> 15569337

Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients.

Simon J Davies1.   

Abstract

BACKGROUND: Time on treatment is associated with a greater risk of impaired ultrafiltration (UF) in peritoneal dialysis (PD) patients. In addition to increasing solute transport, a potentially treatable cause of impaired ultrafiltration, cross-sectional studies suggest that there is also reduced osmotic conductance of the membrane. If this were the case then it would be expected that the UF capacity for a given rate of solute transport would change with time. The purpose of this analysis was to establish how solute transport and UF capacity change relative to one another with time on therapy.
METHODS: Membrane function, using a standard peritoneal equilibration test, was measured at least annually in a well-characterized, single-center observational cohort of PD patients between 1990 and 2003. Demography included age, gender, original cause of renal failure, body surface area (BSA), validated comorbidity score, residual urine volume and urea clearances, peritoneal urea clearances, and plasma albumin.
RESULTS: Data from 574 new PD patients were available for analysis. Independent demographic factors associated with higher solute transport at baseline were male gender and higher residual urine volume. Throughout time on therapy there was a negative relationship between solute transport and UF capacity and a significant increase and decrease in these parameters, respectively. During the first 12 months of treatment, the increase in solute transport was not associated with the expected fall in UF capacity, a phenomenon that was not explained by informative censoring, but was associated with an increased, albeit weak, correlation with BSA. In contrast, later in treatment there was a disproportionate fall in UF capacity, more accelerated in patients developing UF failure. Early exposure to higher intraperitoneal glucose concentrations, in the context of more comorbidity and relative lack of residual renal function, was associated with more rapid deterioration in membrane function.
CONCLUSION: Despite a causal link between solute transport and UF capacity of the membrane, due to the effect of the former on the osmotic gradient, there is evidence of their longitudinal dissociation. This implies a change in the structure-function relationship with time on treatment that can, to some extent, be predicted from clinical factors present within the first year of treatment. Dialysis-induced membrane injury must involve at least two processes, for example, increased vascular surface area contact with dialysate combined with changes in hydraulic conductance due to scarring of the vessels and interstitium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569337     DOI: 10.1111/j.1523-1755.2004.66021.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  52 in total

1.  The Mutual Relationship Between Peritonitis and Peritoneal Transport.

Authors:  Sadie van Esch; Anouk T N van Diepen; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2014-11-13       Impact factor: 1.756

2.  Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus.

Authors:  Uyen Duong; Rajnish Mehrotra; Miklos Z Molnar; Nazanin Noori; Csaba P Kovesdy; Allen R Nissenson; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

3.  The influence of initial peritoneal transport characteristics, inflammation, and high glucose exposure on prognosis for peritoneal membrane function.

Authors:  M José Fernández-Reyes; M Auxiliadora Bajo; Gloria Del Peso; Marta Ossorio; Raquel Díaz; Beatriz Carretero; Rafael Selgas
Journal:  Perit Dial Int       Date:  2012-04-02       Impact factor: 1.756

4.  Role of mitochondrial respiratory chain complex III in high glucose peritoneal dialysate-induced hyperpermeability of HPMCs.

Authors:  Xuejing Zhu; Guanghui Ling; Li Xiao; Yinhong Liu; Shaobin Duan; Youming Peng; Yashpal S Kanwar; Lin Sun; Fuyou Liu
Journal:  Ren Fail       Date:  2010       Impact factor: 2.606

5.  The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.

Authors:  Yu-Pei Fan; Ching-Chih Hsia; Kuang-Wen Tseng; Chih-Kai Liao; Tz-Win Fu; Tsui-Ling Ko; Mei-Miao Chiu; Yang-Hsin Shih; Pei-Yu Huang; Yi-Chia Chiang; Chih-Ching Yang; Yu-Show Fu
Journal:  Stem Cells Transl Med       Date:  2015-12-30       Impact factor: 6.940

6.  Chronic infusion of sterile peritoneal dialysis solution abrogates enhanced peritoneal gene expression responses to chronic peritoneal catheter presence.

Authors:  El Rasheid Zakaria; Paul J Matheson; Ryan T Hurt; Richard N Garrison
Journal:  Adv Perit Dial       Date:  2008

Review 7.  Should peritoneal resting be advised in ultrafiltration failure associated with a fast peritoneal solute transport status?

Authors:  Raymond T Krediet
Journal:  Perit Dial Int       Date:  2014 Nov-Dec       Impact factor: 1.756

8.  The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis.

Authors:  Vincenzo La Milia; Selena Longhi; Elisabetta Sironi; Giuseppe Pontoriero
Journal:  J Nephrol       Date:  2016-12-24       Impact factor: 3.902

9.  Dialysate cytokine levels do not predict encapsulating peritoneal sclerosis.

Authors:  Catriona Goodlad; Frederick W K Tam; Sohail Ahmad; Gurjeet Bhangal; Bernard V North; Edwina A Brown
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

10.  Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling.

Authors:  Manreet Padwal; Imad Siddique; Lili Wu; Katelynn Tang; Felix Boivin; Limin Liu; Jennifer Robertson; Darren Bridgewater; Judith West-Mays; Azim Gangji; Kenneth Scott Brimble; Peter J Margetts
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.